27th issue, April 2015

The ScanBalt EU Research Support Digest informs the members of ScanBalt about relevant open research funding schemes and other financial sources. For further information about ScanBalt see www.scanbalt.org

Join the process towards the Baltic Sea Region as one test site for development of health care products and services.
A process has in 2014 been initiated aiming for the "Baltic Sea Region as one test site for development of health care products and services". If successful this is a huge benefit for SMEs which faster and easier can bring their innovations to the market and it improves the health care offered to patients. For the regions it means more efficient use of existing research and innovation infra-structure and economic development. Read more

Horizon 2020

Societal challenges "Health, demographic change and wellbeing"

Horizon Prize – Better use of Antibiotics

The Horizon Prize for better use of antibiotics is a €1 million prize that will be awarded to the person or team who can most effectively meet the following challenge: develop a rapid test that can identify at the point of care patients with upper respiratory tract infections that can safely be managed without antibiotics.

More information can be found here.

Deadline: 17-08-2016

Horizon 2020 dedicated SME instrument phase 1 and 2

    Topics related to Life Sciences are:
  • BG-12-2015-1: Supporting SMEs efforts for the development - deployment and market replication of innovative solutions for blue growth
  • BIOTEC-5b-2015-1: SME boosting biotechnology-based industrial processes driving competitiveness and sustainability
  • INSO-10-2015-1: SME business model innovation
  • PHC-12-2015-1: Clinical research for the validation of biomarkers and/or diagnostic medical devices

More information can be found here.

Deadline (Cut-off dates): 25-11-2015, 17-06-2015, 17-09-2015, 25-11-2015

Societal challenges "Food security, sustainable agriculture and forestry, marine and maritime and inland water research

Sustainable food security

Topics of this call are:
SFS-14b-2015: Authentication of food products

More information can be found here.

Innovative, sustainable and inclusive bioeconomy

    Funding opportunities related to bio-based economy:
  • ISIB-12c-2015: Monitoring and mitigation of agricultural and forestry greenhouse gases (GHG)
  • ISIB-12e-2015: Sustainable livestock production
  • ISIB-12f-2015: Biomarkers for nutrition and health
  • ISIB-13-2015: Coordination action in support of the implementation by participating States of a Joint Programming Initiative on 'A Healthy Diet for a Healthy Life'
  • ISIB-02-2015: Closing the research and innovation divide: the crucial role of innovation support services and knowledge exchange

More information can be found here.

Deadline: 11-06-2015

Industrial leadership

"Innovation in SMEs"



Topic of this call is:
INNOSUP-5-2014: Peer learning of innovation agencies

More information can be found here.

Deadline (Cut-off dates): 14-10-2015, 14-05-2015, 14-07-2015, 14-10-2015

Innovative Medicines Initiative 2 (IMI 2)

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI 2 - Call 4 2014 is now closed. The following topics are under consideration for inclusion in future calls for proposals to be launched under IMI 2:

  • Patient perspective elicitation on benefits and risks of medicinal products, supplementing benefit risk assessments by regulators and HTAs (health technology assessments) from development through the entire life cycle
  • Development of a quantitative system toxicology (QST) platform
  • Diabetic kidney disease (DKD) biomarker idea
  • Inflammation and Alzheimer’s disease (AD): modulating microglia function – focussing on TREM2 and CD33
  • Enabling magnetic encephalography (MEG) as a biomarker for diagnosis and disease progression in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
  • Understanding the role of amyloid biomarkers in diagnosis, clinical management and treatment of patients with cognitive impairment
  • Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease
  • Bringing apolipoprotein E (APOE) biology to validated Alzheimer’s disease targets

More information can be found here.

Fast Track to Innovation (FTI)

The Fast Track to Innovation (FTI) pilot is a fully-bottom-up measure in Horizon 2020 to promote close-to-the-market innovation activities, and open to all types of participants. FTI will be implemented in 2015 and 2016 with a total budget of €200 million (€100 million per year) across the Horizon 2020 priority "Societal Challenges" and the specific objective "Leadership in Enabling and Industrial Technologies (LEITs)", without further topical restrictions.

The Fast Track to Innovation scheme is open for applications since January 6, 2015. Proposals can be submitted at any time, yet will be ranked three cut-off dates in 2015 (cut-off dates for 2016 will be made public at a later time).

More information can be found here.

Cut-off date(s): 29-04-2015, 01-09-2015, 01-12-2015

The Joint Programming Initiative (JPI) "More Years, Better Lives - The Potential and Challenges of Demographic Change"

The program seeks to enhance coordination and collaboration between European and national research programmes related to demographic change.

The 1st call invites proposals for funding research into one or more of four broad topics: Modern work factors, Longer working life & Inequality, Health challenges & Caring responsibilities.

More information can be found here.

Deadline 02-06-2015

Interreg Baltic Sea Region Programme 2014-2020

The Managing Authority/Joint Secretariat has published a Programme fact sheet for Interreg Baltic Sea Region as an overview for a detailed Programme information.

You can read or download the factsheet here.

The first call in the period 2014 to 2020 is closed, the second call is planned for the end of 2015.

Do you need support in finding the right topic, partner or need further information?

Contact the Steinbeis Team here.



About ScanBalt BioRegion
ScanBalt BioRegion - Health and bio economy on Top of Europe, the Baltic Sea Region

ScanBalt ® fmba promotes the development of ScanBalt BioRegion as a globally competitive health and bio economy

ScanBalt BioRegion Community on LinkedIn

ScanBalt Business Club
Promotes awareness, visibility and match making for companies and organizations located in the Baltic Sea Region.

Publish company portrait free of charge

Investors: Free trial membership of ScanBalt

Get access to potential investment targets in the Baltic Sea region, have discounts on fees for partnering events and conferences, promote your company profile.

 Media Partners